| 绍 | 量发展。公司秉持"稳盘子、谋发展、可持续"的发展理念， | | --- | --- | | | 全面推进组织效能提升、管理机制创新、生产运营优化和市 | | | 场策略升级，在饲料产销规模扩大、生猪养殖效率提升和经 | | | 营业绩改善等方面取得成效。 | | | 2024 年末公司总资产 54.10 亿元，比年初减少 9.58%； | | | 总负债 38.07 亿元，比年初减少 14.08%；所有者权益 16.03 | | | 亿元，其中，归属于母公司所有者权益 15.14 亿元，比期初 | | | 增长 2.28%。2024 年期末资产负债率 70.37%，比期初下降了 | | | 3.7 个百分点。 | | | 2024 年公司实现营业收入 45.62 亿元，同比增长 12.91%； | | | 实现归属于上市公司股东的净利润 3,016 万元，扭亏为盈。 | | | 其中： | | | 1、公司饲料业务保持盈利，实现销量 88.08 万吨（不含 | | | 内销 26.28 万吨），同比增长 29.51%，销售收入 27.68 亿元， | | | 同比增长 6.54%，实现盈利 0.6 ...

Group 1: Company Performance - In 2024, the company achieved a revenue of 1.65 billion and a net profit attributable to shareholders of 1.0055 million [3] - In Q1 2025, the revenue was 325 million, with a net loss attributable to shareholders of 6.101 million [4] Group 2: Product Applications - The company's liquid metal is exclusively supplied to Tesla for the Model X door lock cover [2] - Current applications of liquid metal include components for consumer electronics, new energy vehicles, medical devices, and sports equipment, but not yet in exoskeleton robots [3] Group 3: Financial Management - The company has established a customer credit rating system to manage accounts receivable and reduce bad debt risk [3] - Measures include strict control of accounts receivable limits and aging, as well as regular analysis of accounts receivable quality [3] Group 4: Innovation and Patents - In 2024, the company and its subsidiaries obtained a total of 31 authorized patents, bringing the cumulative total to 314 effective patents and 51 trademarks by the end of 2024 [3] Group 5: Market Strategy - The company aims to deepen market expansion, focus on high-quality clients, and enhance core business market share through technological and R&D innovations [3] - Continuous efforts will be made to optimize governance and enhance information disclosure to maximize company value [4]

Group 1: Financial Performance - In Q1 2025, the company's revenue decreased by 15.31% compared to the same period in 2024, primarily due to a decline in demand for antibiotics and the impact of the "Four Same" policy on product sales and pricing [1] - The total revenue for 2024 saw a year-on-year decline of 5.41%, attributed to the exit of the product Zuo Yi from the hospital market due to centralized procurement [1] Group 2: Product Development and R&D - The company has received approval for clinical trials of the injectable ALK-N001 from the National Medical Products Administration [3] - R&D investment in 2024 is expected to increase significantly due to new investments in innovative drugs and improvements in existing drugs [9] - The compound α-keto acid tablets were selected in the tenth batch of national procurement, with a selected price of 8.52 CNY per box and an estimated procurement volume of 800 million boxes [8] Group 3: Export and Market Strategy - In 2024, the company's export sales amounted to 398 million CNY, accounting for 25.85% of total revenue, with a significant portion of the subsidiary Keri Bio's revenue coming from overseas clients [10] - The company plans to leverage its brand influence to expand the market for Zuo Yi outside hospitals [2] Group 4: Future Expectations - The company aims to enhance sales in 2025 through selected products from national procurement and new products with technical barriers, such as Sacubitril/Valsartan tablets [11] - The animal health technology sector is currently in a loss phase but is expected to become a new growth point as new products are approved and launched [12]

Group 1: Financial Performance - The company's net profit, when combined with R&D expenses, has remained stable or slightly increased over recent years despite challenges in the pharmaceutical industry [1][2] - The raw material drug business has remained stable, while the specialty intermediate business has shown significant performance [2] - The sales volume and price of Benzylsulfonyl L-lysine tablets have been significantly impacted since the second half of 2023 due to national procurement policies [2] Group 2: R&D and Product Development - The company plans to shift focus from generic drugs to improved new drugs and innovative drugs, aiming for a "generic-innovative synergy" strategy [2] - The R&D budget for 2025 is expected to remain high, with Q1 R&D expenses reported at 51.8 million yuan [7] - The company has received approval for clinical trials of ALK-N001, indicating progress in its innovative drug pipeline [3][7] Group 3: Market Strategy and Product Launches - The company aims to leverage its existing brand influence to expand the market for L-lysine tablets, focusing on outpatient sales channels [4] - New products with technical barriers, such as Sacubitril/Valsartan tablets, have been launched, with future sales dependent on various market factors [3] - The company is actively pursuing new drug registrations in the pet medicine sector, with plans to double sales in 2024 [3] Group 4: Regulatory and Policy Impact - The company is preparing for the 11th batch of national procurement policies, which have not yet been announced [8] - The impact of the "Four Consistencies" policy has led to a decline in sales and prices for certain products, but the company expects stabilization as policies mature [4][8] - The export revenue accounted for 25.85% of total revenue in 2024, with significant markets including the U.S. and Europe [5]

从市场传播看，我们希望市场投资者能对公司更加有信心，在 2024 年年报披露中，针对 2022 年的回购股份公司同步推出了员 工持股计划，经过两年的打磨和转型，公司业务目标更加明确， 实施员工持股计划将充分调动骨干力量的积极性。员工持股计划 中的考核目标，虽不代表公司的业绩承诺，但公司业务团队对达 成目标充满信心。 二、问答环节 问题 1：公司如何看待主营业务社保服务这几年相对下降情况？ 未来几年第三代社保卡（以下简称"三代卡"）的发卡节奏会加 快吗？ 证券代码：002908 证券简称：德生科技 广东德生科技股份有限公司 投资者关系活动记录表 编号：2025-003 | 投资者关系活动类 | 特定对象调研 分析师会议 | | --- | --- | | 别 | □媒体采访 业绩说明会  | | | □新闻发布会 路演活动 | | | 现场参观  其他（电话会议） | | 参与单位名称及人 | 同泰基金、鸿运私募、创富兆业、磐厚资本、明豪能源公司、望 | | 员姓名 | 睿投资、IncTar Cap、九祥资产、广东数联、润桂投资、果行育 | | | 德公司、云众创融、浙商资管、广发证券、东北证券、国 ...

Financial Performance - In 2024, the company achieved a revenue of CNY 6.17 billion, a year-on-year increase of 28.46% [1] - The net profit attributable to shareholders was CNY 462 million, up 19.29% year-on-year [1] - R&D investment reached CNY 304 million, a growth of 40.87% compared to the previous year [1] - The revenue growth rate exceeded the net profit growth rate primarily due to an additional CNY 21.34 million in share-based payment expenses [1] Revenue Breakdown - Charging products saw a revenue increase of 50.87% [2] - Transmission products grew by 21.30%, audio-video products by 11.64%, storage products by 19.29%, and mobile peripherals by 16.21% [2] - Domestic revenue accounted for 42.53% of total revenue, growing by 10.11%, while overseas revenue made up 57.47%, increasing by 46.46% [2] Geographic Performance - The Asia (excluding mainland China) region contributed 20.68% of total revenue, with a growth of 50.07% [2] - Europe contributed 19.16% of revenue, up 45.80%, and the Americas contributed 15.7%, growing by 39.92% [2] - Other regions contributed 1.93% of revenue, with a significant increase of 75.93% [2] Sales Channels - Online sales represented approximately 75% of total revenue, primarily through platforms like Amazon, JD.com, and Tmall [2] - Offline sales accounted for about 25% of total revenue [2] Q1 2025 Performance - In Q1 2025, the company reported revenue of CNY 1.82 billion, a year-on-year increase of 41.99% [2] - The net profit attributable to shareholders for Q1 2025 was CNY 150 million, up 47.18% year-on-year [2] Inventory and Supply Chain - Inventory increased due to rapid growth in NAS and mobile power businesses, necessitating early procurement payments [4] - The company is expanding its product offerings in the new energy sector, including car-mounted charging pumps and lithium iron phosphate batteries [4] Market Strategy - The company is focusing on enhancing its market penetration in emerging markets, particularly in Asia (non-mainland) and Europe [6] - Despite rising shipping costs, the impact on business and profitability has been minimal, as shipping costs account for about 2% of the main business costs [6] Profitability - In 2024, the gross margin for domestic business was 28.30%, while for overseas business it was 44.11% [8] - The company is actively working on product innovation and cost optimization to maintain competitiveness in overseas markets [8] Talent Management - The company employs a dual strategy of internal development and external recruitment to attract and retain talent [9] - A competitive compensation system is in place to incentivize and retain skilled employees [9]

广东万年青制药股份有限公司投资者活动记录表 编号：20250430 投资者关系活动 类别 □特定对象调研 □分析师会议 □媒体采访 ☑业绩说明会 □新闻发布会 □路演活动 □现场参观 □电话会议 其他： 参与单位名称 及人员姓名 线上参与2024年度暨2025年第一季度网上业绩说明会的投资 者 时间 2025 年 4 月 30 日(周三)15:00-16:00 地点 价值在线（www.ir-online.cn） 公司接待人员 姓名 董事长、总裁：欧先涛先生 董事、副总裁、财务总监兼董事会秘书：陈秀燕女士 独立董事：李华青先生 董事、子公司总经理：颜文孟先生 子公司总经理：张建朝先生 投资者关系活动 主要内容介绍 本次业绩说明会采用网络方式进行，公司参会人员与投资者 就公司经营情况和未来发展等情况进行了充分的交流与沟 通，主要问题及答复如下： 1.听说贵公司的销售管理岗位 流动性非常大 这是什么原因 呢 答:您好，公司在药品、医疗及大健康消费方面设立多个销售 管理岗位，销售管理岗位属于业务及服务前端管理岗位，对 人才需求更偏向于复合型人才，加上新业态原因，相比其他 管理岗位流动性偏大属于正常现象。 2.目前在数 ...

Business Direction and Development - The company focuses on two main business segments: quality energy asset management (including waste-to-energy, photovoltaic power generation, energy storage, and microgrid construction) and resource utilization, particularly the recovery of rare and precious metals. The company has established a presence in key regions such as Zhejiang, Shenzhen, and Hunan, with plans for nationwide expansion [1]. - In 2025, the company will concentrate on quality energy asset management and resource utilization, with key areas in the Pearl River Delta, Yangtze River Delta, and Hunan. The new energy engineering business will include wind power, photovoltaic, energy storage, and microgrid projects, while the environmental business will focus on soil remediation, air pollution control, and landfill management [1]. Market Expansion and Competitive Advantages - The company is expanding its dual-carbon business, leveraging competitive advantages such as a short decision-making chain, rapid deployment capabilities, and agile project management. It offers comprehensive services including new energy project investment, construction, operation, and carbon asset management [2]. - The company has accumulated a large number of high-quality clients and will continue to pursue a major client strategy, focusing on high-energy-consuming clients in need of low-carbon transformation [2]. - Innovative business models are being explored, such as integrating photovoltaic with microgrids and waste-to-energy with data assets, to secure quality project resources [2]. Financial Performance - In 2024, the company achieved a revenue of CNY 760.21 million, a year-on-year increase of 17.71%. The net profit attributable to shareholders was CNY 98.29 million, up 23.10%, with a significant increase of 112.66% in net profit after deducting non-recurring gains and losses [8]. - The profit distribution plan for 2024 includes a cash dividend of CNY 0.90 per 10 shares, based on a total share capital of 645,622,165 shares [9]. Research and Development Focus - Future R&D efforts will focus on high-value rare and precious metal resource utilization and the application of source-network-load-storage systems, ensuring the advancement and practicality of related technologies [10]. Competitive Edge and Strategic Partnerships - The company maintains core competitiveness through national-level technology platforms and a range of competitive core technologies in soil remediation, ultra-low emissions, and waste-to-energy [4][5]. - The company has extensive project experience and management capabilities, with stable operations in various waste treatment projects, contributing to urban development [6]. - Strategic partnerships with high-end clients and cooperation with state-owned enterprises and leading private companies enhance the company's service capabilities in providing dual-carbon consulting and comprehensive services [7].

Group 1: Financial Performance - In Q1 2025, the company achieved a revenue of 979 million, representing a year-on-year growth of 22.32% [2] - The company's gross profit margin in Q1 2025 was 38.84%, an increase of 0.91 percentage points compared to the previous year [4] - The company plans to achieve a revenue target of 5 billion in 2025 [3] Group 2: International Expansion and Capacity Utilization - As of 2024, the company's overseas capacity accounted for 19.05%, with a utilization rate of 47.98% [5] - The utilization rate of the Vietnam factory is expected to increase significantly due to a positive order trend [5] Group 3: Strategic Responses to Market Challenges - The company is adopting proactive measures to mitigate the impact of tariffs and international order shifts, including enhancing communication with downstream clients and expanding into new markets [6][7] - The company emphasizes cost control while balancing capacity planning between domestic and international operations [6] Group 4: Competitive Positioning - The company differentiates itself from YKK through its "product + service" model, focusing on quality products and comprehensive service [8] - The apparel accessories industry is expected to see increased competition due to tariffs, but companies with strong international capabilities will have an advantage [9] Group 5: Future Business Outlook - The company is optimistic about the future of its zipper business, which has a larger market potential compared to buttons [10] - The company maintains a commitment to sustainable development and plans to implement a reasonable profit distribution policy [11]

Financial Performance - In 2024, the company achieved a revenue of 162.64 billion CNY, a year-on-year increase of 0.35% [1] - The net profit attributable to shareholders for 2024 was 6.53 billion CNY, a decline of 10.14% compared to the previous year [1] - In Q1 2025, the company reported a revenue of 35.67 billion CNY, reflecting a growth of 0.75% [1] - The net profit for Q1 2025 was 2.75 billion CNY, showing a significant increase of 21.3% year-on-year [2] Business Segments - The automotive metal parts lightweighting segment generated a revenue of 134.50 billion CNY, with a slight increase of 0.09% [2] - The general aviation aircraft manufacturing segment achieved a revenue of 28.14 billion CNY, growing by 1.62% [2] - The sales of aluminum alloy wheels reached 22.34 million sets, marking a year-on-year growth of 17.27% [2] Strategic Initiatives - The company is focusing on optimizing product structure and deepening cooperation in the new energy sector [1] - Following the acquisition of Volocopter's core assets, the company aims to integrate resources and enhance its eVTOL business [3] - The company plans to develop a multi-scenario product travel matrix, including fixed-wing, vertical take-off and landing aircraft, and drones [3] eVTOL Product Development - The company is developing urban air mobility solutions with the Volocopter 2X and VoloCity models, targeting certification by 2025-2026 [5] - The intercity air mobility solutions will utilize VoloRegion and VoloConnect models, designed for high endurance and speed [5] - The drone solutions, based on eVTOL technology, can carry up to 200 kg over a range of 40 km, targeting logistics in hard-to-reach areas [5] Global Market Strategy - The company has established manufacturing bases in Canada, Mexico, and the USA to mitigate tariff impacts, with less than 4% of sales to the US market affected by tariffs [6] - The company is enhancing its market share in the Asia-Pacific region, particularly among mid-to-high-end customers [6] - The strategy includes leveraging opportunities in the new energy vehicle market to integrate into core customer supply chains [6]